Application 210246
- Type
- ANDA
- Sponsor
- APOTEX
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | INJECTABLE;INJECTION | 0.2MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16714-536 | Glycopyrrolate | Glycopyrrolate | NORTHSTAR RX LLC | ANDA | Current |
| 16714-536 | Glycopyrrolate | Glycopyrrolate | NORTHSTAR RX LLC | ANDA | Current |
| 16714-620 | Glycopyrrolate | Glycopyrrolate | NORTHSTAR RX LLC | ANDA | Current |
| 16714-620 | Glycopyrrolate | Glycopyrrolate | NORTHSTAR RX LLC | ANDA | Current |
| 60505-6179 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6179 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6179 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6180 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6180 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6180 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6181 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6181 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6181 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6182 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6182 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 60505-6182 | Glycopyrrolate | Glycopyrrolate | Apotex Corp. | ANDA | Current |
| 71872-7227 | Glycopyrrolate | Glycopyrrolate | Medical Purchasing Solutions, LLC | ANDA | Current |
| 71872-7237 | Glycopyrrolate | Glycopyrrolate | Medical Purchasing Solutions, LLC | ANDA | Current |